Ear Buds, Real Data: How AirPods Quietly Became a Life Sciences Tool in 2026

Independent researchers in Ireland have confirmed that AirPods Pro 3 can track heart rate almost as accurately as a hospital-grade chest strap, an audiology team has shown that AirPods Pro 2 can screen hearing loss nearly as well as a booth-based hearing test in a third of the time, and Apple’s own study with the University of Michigan, now covering more than 160,000 people, has used that same technology to uncover a genuine link between hearing loss and how fast older adults walk. A pair of consumer earbuds bought primarily for music has quietly become one of the more interesting research instruments in life sciences.

AirPods were not designed as medical devices. They were designed to sell music and phone calls. What has changed in the past two years, and become especially clear in 2026, is that the sensors Apple added to make its earbuds smarter, an optical heart rate sensor, a microphone array capable of doubling as an audiometer, have turned out to be accurate enough, and installed on enough ears, that independent scientists are now treating them as legitimate research tools rather than gadgets.

An Independent Check on the Heart Rate Sensor

In April, a team led by Rory Lambe at the Insight Research Ireland Centre for Data Analytics, University College Dublin, published a laboratory validation study in PLOS Digital Health testing whether AirPods Pro 3’s built-in optical heart rate sensor could be trusted during exercise, historically a hard test for any wearable sensor. Forty healthy adults completed a graded treadmill protocol, walking and running through stages designed to push their heart rate to between 40% and 85% of their age-predicted maximum, while wearing AirPods Pro 3 alongside a Polar H10 chest strap, a device already validated against ECG as a reference standard.

Across 16,735 paired five-second measurement windows, the AirPods Pro 3 came out very close to the chest strap: an average bias of just −0.03 beats per minute, meaning no meaningful tendency to over- or under-read, and an overall mean absolute error of 2.08 beats per minute, or about 2.02% of the true reading. The one caveat, and it is an important one, is that individual readings became noticeably less consistent at higher exercise intensities, even though the average across the group stayed accurate. The study’s own summary is blunt about what that means in practice: AirPods Pro 3 can provide “useful heart rate information for fitness tracking in healthy adults,” but “should not replace clinical-grade equipment when high precision is required.” That is a genuinely useful distinction, and one that only exists because someone with no commercial stake in Apple’s products decided to test the claim properly.

A Hearing Test in Under Six Minutes

The second strand of evidence concerns hearing rather than heart rate. Apple’s Hearing Test Feature, built into AirPods Pro 2 and paired with an iPhone, has been marketed since 2024 as a way to check for hearing loss at home. This year, a research team led by M. Kruger, Vinaya Manchaiah and De Wet Swanepoel put that feature through a formal clinical comparison against pure-tone audiometry, the standard hearing test performed by an audiologist in a sound-treated booth, publishing their findings in Otolaryngology–Head and Neck Surgery.

Twenty-five adults with self-reported mild-to-moderate hearing loss each completed a full audiologist-administered hearing test followed by two independent AirPods-based tests, generating 400 threshold comparisons in total. The results held up well: 86.5% of the AirPods-derived thresholds fell within 10 decibels of the professional test, meeting the accuracy bar researchers had set in advance, and repeat testing on the same people was consistent, with 96.6% of thresholds landing within 10 decibels on a second attempt. The standout figure, though, was speed. The AirPods test took a median of 5.5 minutes, against 10 minutes for the full professional assessment, a statistically significant difference the researchers noted could matter a great deal for getting more people screened in the first place. Their conclusion was cautiously optimistic: the feature showed “clinically acceptable accuracy and test-retest reliability,” useful groundwork for consumer-led hearing monitoring, though they were clear that further work is needed on how it performs across different devices and real-world conditions.

What Happens When 160,000 People Wear the Same Sensor

The most striking result this year, though, did not come from a small validation study at all. It came from scale. The Apple Hearing Study, run in partnership with the University of Michigan, has now enrolled more than 160,000 consented participants across the United States, making it one of the largest hearing research efforts ever conducted, precisely because it does not require anyone to visit a clinic. New findings released in May drew on that dataset to answer a question a small trial never could: what does hearing loss actually mean for people’s day-to-day lives?

Among nearly 85,000 participants who tested within the World Health Organization’s definition of “normal” hearing, 16% still rated their own hearing as fair or poor, and many reported real difficulty concentrating on speech or following conversations against background noise, despite passing the clinical threshold. In a separate analysis of 57,183 participants, the researchers found that worse hearing was associated with slower walking speed, a well-established marker of physical health and ageing, with the effect most pronounced in adults aged 60 and over. The study’s authors were careful to frame the implication constructively rather than alarmingly, writing that giving people the ability to track their own hearing over time, using the same four-frequency pure tone average measured by the Hearing Test Feature, “gives them the opportunity to track their hearing as it changes over time, even when classified as clinically normal, and to take steps to protect and assist their hearing over their lifetime.” They added that addressing hearing loss through tools like the Hearing Aid Feature “may help promote physical health over the life course.”

From Gadget to Instrument

None of these three results would exist if AirPods were simply popular. What made them useful to life sciences is the combination of the two things above: sensors accurate enough to survive independent scrutiny, and an installed base large enough to turn a niche clinical question into a population-level study almost overnight. A heart rate validation study with 40 participants and a hearing feasibility study with 25 are the kind of modest, careful science that ordinarily takes years to scale into anything with public health relevance. Apple’s own study, built on the exact same underlying technology, reached population scale in a fraction of that time simply because the sensor was already sitting in millions of ears. That is not a reason to treat consumer wearables as a substitute for clinical-grade medicine, as every study here is careful to say. It is a reason to take seriously what happens when ordinary consumer electronics are built well enough, and checked rigorously enough, to become part of the evidence base themselves.

Sources include PLOS Digital Health, Otolaryngology–Head and Neck Surgery, the Apple Hearing Study, the University of Michigan School of Public Health, and 9to5Mac.

Author

Leave A Comment

Graham Combe

Strategic Consultant,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Graham Combe is an experienced strategic consultant, relationship builder, and entrepreneur in the global life sciences sector. He holds a BSc (Hons) in Chemistry from University College London (UCL) and spent over a decade with Nature, where he pioneered key initiatives such as Nature’s BioPharma Dealmakers and Nature’s SciCafe.

In May 2011, he founded Biosell UK, a consulting and event management firm that collaborates with global life science publishers, event organizations, and marketing partners. Beyond BioSell, Combe is the founder or co-founder of several prominent networking and thought-leadership platforms, including #BiotechBuddies, #coffeebuddies, the #AgileLeaders Forum, and the Creative Disruption Forum—the latter three events co-hosted with his business partner, Professor Tony Sedgwick.

Specializing in the early-to-mid stages of drug development (from pre-clinical research through Phase 3 and clinical proof-of-concept), Graham focuses on facilitating forums to promote peer-to-peer discussion, strategic growth, investment and meaningful connections between biotech innovators, investors, and industry service providers.

Secure your Launch Day Conference Pass

Be in the room where the future of life sciences is shaped.

Early Bird until 31 August: Save £155

Apply for a complimentary Conference Day VIP Pass

Apply for a complimentary Conference Day VIP Pass

Complimentary Conference Day VIP Passes are reserved for senior leaders and decision-makers with influence over purchasing, commissioning, investment or technology advancements and adoption across UK life sciences.

A Conference Day VIP Pass includes:

  • Complimentary access-all-areas to the Launch Day Conference
  • Access to the dedicated VIP green room alongside Conference speakers
  • Access to all general keynote, panel and programme sessions
  • Curated networking opportunities
  • Opportunities to meet conference speakers and other approved VIP attendees

The VIP Pass applies to the Launch Day Conference only. It does not include admission to the Life Sciences Week Gala Dinner or other separately ticketed events.

Applications are reviewed individually and submitting this form does not guarantee a complimentary pass. To maintain a balanced, high-quality audience, we may limit the number of VIP Passes issued to any one organisation.

    First Name *

    Last Name *

    Work Email Address *

    Telephone Number *

    Job Title *

    Organisation *

    LinkedIn

    Organisation Information

    Which best describes your organisation? *


    If other, please specify

    Which best describes your level of seniority? *

    If other, please specify

    Which areas are you responsible for or directly involved in? *

    If other, please specify

    What best describes your role in purchasing, investment, commissioning or adoption decisions? *

    Attendance Information

    Briefly, what is the number one thing you are hoping to get out of attending Life Sciences Week 2026? *

    Final Confirmation

    Is your role primarily focused on selling products or services, consultancy, account management or business development? *

    Please Confirm *

    I understand that VIP applications are subject to review and approval.
    I understand that the complimentary VIP Pass covers the Life Sciences Week Launch Day Conference only and does not include the Gala Dinner Awards or other separately ticketed events.
    The information supplied in this application is accurate.

    Shabna Raja

    Advisory Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

    She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
    initiatives across commercial, data and operating model domains within regulated environments.

    Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

    More recently, she has spent over three years working closely with Haleon through a strategic
    services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

    Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

    Amjad Khan

    Executive Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

    Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt and scale emerging  technologies to drive meaningful outcomes.

    Dr. Richard Fallon | Business Consultant | WM Life Sciences

    Dr. Richard Fallon

    Co Founder, Life Sciences Week 
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

    As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

    Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

    With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

    Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

    Amy Deakin | Chief of Staff | WM Life Sciences

    Amy Deakin

    Event Managing Director,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

    Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

    Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

    An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

      Award Category Voting

      Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

      Day you've not voted in, will be denoted with an ❌

      If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

      Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

      Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

      No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

      Awarding an individual or organisation for exceptional long-term impact on the industry.

      No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

      Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

      No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

      Your Details